Esther Rajavelu
Stock Analyst at UBS
(0.67)
# 3,863
Out of 4,876 analysts
28
Total ratings
43.75%
Success rate
-23.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $331 → $349 | $322.83 | +8.11% | 6 | May 2, 2025 | |
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.32 | +517.67% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $14.10 | +126.95% | 2 | Apr 9, 2024 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $36.52 | +99.89% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $14.09 | +673.60% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $11.63 | +201.08% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $39.80 | -5.78% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $106.90 | +113.28% | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $10.88 | - | 2 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $16.08 | - | 1 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $13 | $19.96 | -34.87% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.12 | +792.86% | 1 | Jul 21, 2017 |
Alnylam Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $331 → $349
Current: $322.83
Upside: +8.11%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.32
Upside: +517.67%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $14.10
Upside: +126.95%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $36.52
Upside: +99.89%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $14.09
Upside: +673.60%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $11.63
Upside: +201.08%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $39.80
Upside: -5.78%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $106.90
Upside: +113.28%
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $10.88
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $16.08
Upside: -
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $19.96
Upside: -34.87%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.12
Upside: +792.86%